Sonrotoclax and Zanubrutinib Are a Strong Combination in CLL - Dr. Tam and Dr. Koffman
In frontline CLL patients, taking sonrotoclax 320 mg plus zanubrutinib led to undetectable measurable disease (uMRD) in 92% at 48 weeks and 98% at 96 weeks. Dr. Constantine Tam from Monash University in Melbourne, Australia, and colleagues presented the results at the 2025 American Society for Hematology (ASH) Annual Meeting. Read the full article on CLL Society's website at: https://cllsociety.org/2026/05/sonrot... __________________________________________________________________________________________ CLL Society Website: https://cllsociety.org/ Facebook: / cllsociety Twitter: / cllsociety LinkedIn: / cll-society
▶︎
Ongoing Trial: Adding Venetoclax to BTK Inhibitors for CLL - Dr. Koffman and Dr. John Burke
▶︎
Sonrotoclax and Obinutuzumab for Treatment-Naïve CLL - Dr. Marc Hoffmann and Dr. Paul Hampel
▶︎
Understanding Treatment Sequencing in CLL
▶︎
Grounding Clinical AI: From Hospital Cross-Cover to Oncology Billing Automation
▶︎
Myeloma 101: Understanding Multiple Myeloma, Risk Factors, Diagnosis & Treatments Explained
▶︎
New & Emerging Treatments for CLL - 2026
▶︎
Delaying Obinutuzumab with Acalabrutinib and Venetoclax - Dr. William Wierda and Dr. Ryan Jacobs
▶︎
CLL / Chronic Lymphocytic Leukemia: EXPLAINED!
▶︎
RA Remission Without Methotrexate or Biologics — A Real Patient Story That Will Blow Your Mind
▶︎
First-Line Therapies and Biomarker Testing in Patients with CLL-Dr. Paul Hampel & Dr. Alexey Danilov
▶︎
FAQs: Immunotherapy for Multiple Myeloma: Exploring Options Through Your Disease Journey
▶︎
Why Aromatase Inhibitors Make You So TIRED (and What to Do)
▶︎
CLL Genetic Marker Testing Associated with Better Outcomes - Dr. Brian Koffman & Dr. Alexey Danilov
▶︎
What Does The Future Hold for Thoracic Oncology and AI Use in Cancer?
▶︎
Zanubrutinib Shows Strong Six-Year Efficacy in Frontline CLL - Drs. Constantine Tam & Brian Koffman
▶︎
Hemochromatosis / Iron Overload Explained
▶︎
Relapsed Multiple Myeloma: What Every Patient Needs to Know
▶︎
Venetoclax vs Covalent BTKi in Real World Older CLL Patients - Dr. Scott Huntington and Dr. Koffman
▶︎
These Two Drugs Eliminated Cancer Metastasis | Here's What You Need to Know
▶︎